Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Eris Lifesciences Limited Call Transcript 2025

Nov 14, 2025

61253_rns_2025-11-14_ce59be32-8773-4f2c-86dd-cf22831708de.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [594 x 63] intentionally omitted <==

==> picture [594 x 63] intentionally omitted <==

Date: 14 November 2025

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS

SUBJECT: TRANSCRIPT OF ANALYST AND INVESTOR CALL

Dear Sir/Madam,

This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter and half year ended September 30, 2025, is available on our website at URL https://eris.co.in/financials/

(File name: Transcript of the Analyst and Investor Conference call Q2FY26).

Thanking You,

For Eris Lifesciences Limited

Digitally signed by Milind Milind Talegaonkar Talegaonkar Date: 2025.11.14 15:32:03 +05'30'


Milind Talegaonkar Company Secretary and Compliance Officer ICSI Mem. No. A26493

==> picture [592 x 72] intentionally omitted <==